Embecta Corp. Files 2025 Proxy Statement

Ticker: EMBC · Form: DEF 14A · Filed: Dec 19, 2024 · CIK: 1872789

Embecta CORP. DEF 14A Filing Summary
FieldDetail
CompanyEmbecta CORP. (EMBC)
Form TypeDEF 14A
Filed DateDec 19, 2024
Risk Levellow
Pages14
Reading Time17 min
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, annual-meeting, governance

TL;DR

Embecta Corp. proxy statement filed for 2025 shareholder meeting on Feb 12.

AI Summary

Embecta Corp. filed its definitive proxy statement for its 2025 annual meeting of stockholders, scheduled for February 12, 2025. The filing, submitted on December 19, 2024, outlines the agenda and proposals to be voted on by shareholders. Embecta Corp., formerly Berra Newco, Inc., is a company specializing in surgical and medical instruments.

Why It Matters

This filing provides shareholders with crucial information regarding the company's governance and upcoming decisions, allowing them to make informed voting choices.

Risk Assessment

Risk Level: low — This is a routine proxy filing providing information to shareholders and does not inherently present new risks.

Key Numbers

Key Players & Entities

FAQ

What is the purpose of a DEF 14A filing?

A DEF 14A filing, or definitive proxy statement, is used by companies to solicit proxies from shareholders when seeking shareholder approval for certain corporate actions or to elect directors.

When was Embecta Corp. formerly known as?

Embecta Corp. was formerly known as Berra Newco, Inc., with a date of name change on 20210714.

What is the SIC code for Embecta Corp.?

The Standard Industrial Classification code for Embecta Corp. is 3841, which corresponds to Surgical & Medical Instruments & Apparatus.

What is the fiscal year end for Embecta Corp.?

Embecta Corp.'s fiscal year ends on September 30 (0930).

What is the filing date of this proxy statement?

This definitive proxy statement was filed on December 19, 2024.

Filing Stats: 4,333 words · 17 min read · ~14 pages · Grade level 14 · Accepted 2024-12-19 16:17:34

Filing Documents

: Gender Identity

Part I: Gender Identity Female Male Directors 3 6

: Demographic Background

Part II: Demographic Background African American or Black - 2 Alaskan Native or Native American - - Asian - 1 Hispanic or Latinx - - Native Hawaiian or Pacific Islander - - White 3 3 Two or More Races or Ethnicities - - LGBTQ+ - Did Not Disclose Demographic Background - Military Service 2 In addition to gender and demographic diversity, we also recognize the value of other diverse attributes that directors may bring to our Board, including veterans of the U.S. military. We are proud to report that of our nine current directors, two are also military veterans. Director skills and experience The Board values having directors who possess a wide variety of relevant skills, professional experience, and backgrounds, bring diverse viewpoints and perspectives, and effectively represent the long-term interests of stockholders. Listed below are certain of the key skills and experience that the Board considers important for our directors to have in light of our current business in order to contribute to the effective leadership and exercise of oversight responsibilities by the Board. Medical Device / Medical Professional Experience with and knowledge of our industry and technologies, as well as our end markets or credentialed or licensed as a professional in any of the medical fields, such as a registered nurse, physician or medical technician. Executive Leadership Experience in executive-level positions, such as at large multi-national companies, including public company board experience. Global / International Business Experience in a leadership role at an organization with global or international operations. Financial and Accounting Experience with financial matters, such as financial markets, financing operations, or accounting and financial reporting processes. Operations and Manufacturing Experience with and understanding of operations or manufacturing processes. Strategy and Innovation Experience with understandin

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on Read The Filing